Robert P. Edwards

IL‐12 receptor‐mediated upregulation of FasL in human ovarian carcinoma cells

J. Grandis, A. Lokshin, E. Gorelik, 2004, International journal of cancer.

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

C. Tannenbaum, P. Rayman, P. Pavicic, 2023, Oncoimmunology.